Showing results (81-90 of 201) with videos related to
Sort By:
Pageof 21
Nature Genetics|February 12, 2008
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerJulius Gudmundsson, Patrick Sulem, Thorunn Rafnar, et al.Human Molecular Genetics|March 29, 2013
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expressionZsofia Kote-Jarai, Edward J Saunders, Daniel A Leongamornlert, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2018
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT StudyCharleen D Adams, Rebecca Richmond, Diana L Santos Ferreira, et al.Nature Communications|November 7, 2018
Germline variation at 8q24 and prostate cancer risk in men of European ancestryMarco Matejcic, Edward J Saunders, Tokhir Dadaev, et al.Nature Communications|January 19, 2019
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestryMarco Matejcic, Edward J Saunders, Tokhir Dadaev, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 27, 2015
Genome-wide association study of prostate cancer-specific survivalRobert Szulkin, Robert Karlsson, Thomas Whitington, et al.The Lancet. Oncology|October 22, 2021
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective studyElizabeth K Bancroft, Elizabeth C Page, Mark N Brook, et al.Human Molecular Genetics|July 12, 2015
Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regionsYing Han, Dennis J Hazelett, Fredrik Wiklund, et al.British Journal of Cancer|January 5, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.European Urology|February 4, 2014
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studyElizabeth K Bancroft, Elizabeth C Page, Elena Castro, et al.Pageof 21